AMEND SECTION. 5.2. Section 5.2 of the Agreement is hereby amended to add the following sentence: "Notwithstanding the rights granted in Section 5.1(a), Lilly may only use SGX Materials which include or are generated by SGX using, reagents obtained by SGX from [...***...] Corporation and which are identified by SGX in writing as "[...***...] Materials", for Lilly's internal research purposes (on its own behalf or on behalf of its collaborators).
Appears in 2 contracts
Sources: Amendment to Agreement (SGX Pharmaceuticals, Inc.), Amendment to Agreement (SGX Pharmaceuticals, Inc.)